Premium
The mechanism and potential targets of class II HDACs in angiogenesis
Author(s) -
Hou Fei,
Li Dandan,
Yu Honglian,
Kong Qingsheng
Publication year - 2018
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.26476
Subject(s) - angiogenesis , histone deacetylase , epigenetics , mechanism (biology) , histone , cancer research , disease , cancer , biology , immunology , medicine , bioinformatics , genetics , dna , gene , philosophy , epistemology
Angiogenesis refers to the new blood vessels deriving from the existing blood vessels, and it is a complex regulatory process. Angiogenesis is associated with the normal development of the body and tumor growth and migration. The imbalance of histone deacetylase, as an epigenetic modification, could induce the production of diseases, such as cancer, metabolic diseases, etc., and it also plays an important role in angiogenesis. Many researches indicate that class II HDACs nuclear shuttle and its phosphorylation are necessary for the diseases and the protection of the collective itself. This paper will make a review for the relationship between II HDACs and angiogenesis under physiological and pathologic categories, looking forward to the disease treatment in the future.